Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril valsartan in chronic heart failure patients on hemodialysis
jRCT1031230599Recruiting
- Sponsor
- Chiba University Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sacubitril + valsartan in chronic heart failure (CHF), sponsored by Chiba University Hospital. Primary endpoint: Serious adverse events associated with sacubitril valsartan administration. Started Apr 2024; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on jRCT1031230599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230599.